Related Experiment Video
Updated: May 8, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Maternal and infant vitamin D status during the first 9 months of infant life-a cohort study
S Við Streym1, U Kristine Moller, L Rejnmark
1Department of Endocrinology and Internal Medicine (MEA), Aarhus University Hospital, Aarhus, Denmark.
Insights
Vitamin D deficiency is common in newborns, with 61% having low levels at birth. Maternal vitamin D levels above 50 nmol/l are crucial to prevent deficiency in infants.
Area of Science:
- Maternal and infant health
- Nutritional science
- Pediatrics
Background:
- Low plasma 25-hydroxyvitamin D (25OHD) levels can impact maternal and infant health.
- Assessing vitamin D status is crucial for identifying at-risk populations.
Purpose of the Study:
- To evaluate vitamin D status in healthy mothers and their infants.
- To investigate the consequences of low 25-hydroxyvitamin D (25OHD) levels.
Main Methods:
- A cohort of 107 women and 108 infants was followed for 9 months.
- Plasma 25-hydroxyvitamin D (25OHD) levels were measured in mothers and infants.
- Cord blood parathyroid hormone levels were assessed.
Main Results:
- 61% of infants and 23% of mothers had 25OHD levels below 50 nmol/l at birth.
- Infant vitamin D deficiency (25OHD<25 nmol/l) was significantly higher in infants born to mothers with 25OHD <50 nmol/l.
- Supplementation led to >85% of infants having 25OHD >50 nmol/l during follow-up.
Conclusions:
- Vitamin D deficiency is prevalent in newborns.
- Maternal 25OHD levels exceeding 50 nmol/l are necessary to prevent neonatal vitamin D deficiency.
Background/Objectives:
The objective of this study was to assess vitamin D status and possible consequences of low plasma 25-hydroxyvitamin D (25OHD) levels in a population of healthy mothers and their infants.
Subjects/Methods:
A total of 107 women aged 24-41 years gave birth to 108 infants. They were followed up three times during 9 months.
Results:
Cord blood 25OHD level (43.3 ± 20.4 nmol/l) on average was 62 ± 16% of maternal levels (73.3 ± 30.7 nmol/l), measured 1-2 weeks postpartum. Cord blood 25OHD correlated positively with maternal 25OHD levels (r=0.83, P<0.001). At birth, 23% of mothers and 61% of infants had 25OHD <50 nmol/l. Vitamin D deficiency (25OHD<25 nmol/l) was present in 66% of the children born by mothers with 25OHD levels below 50 nmol/l (P<0.01), whereas only one child was born with deficiency among mothers with 25OHD >50 nmol/l. During follow-up, most of the children (>85%) had 25OHD levels >50 nmol/l, which most likely was attributable to the use of supplements, as more than 95% of the children were given daily vitamin D supplements of 10 μg of vitamin D.Cord blood parathyroid hormone levels were very low (median 0.21; interquartile range 0.11-0.33 pmol/l), with increasing levels (P<0.01) reaching 3.08 (2.67-3.92 pmol/l) at the last visit. Vitamin D levels were not associated with anthropometric indices of the newborn infant or their growth during follow-up.
Conclusions:
Vitamin D deficiency is widespread in newborn. Maternal 25OHD levels above 50 nmol/l are needed to prevent vitamin D deficiency among newborn.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Development of Human Microbiota
Development of the Oral Microbiota
Drug Dosing: Infants and Children
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...